Hepatitis C - Peregrine Pharmaceuticals, Inc. (PPHM) to Present At Rodman & Renshaw Annual Healthcare Conference

Peregrine Pharmaceuticals, Inc. (PPHM) to Present At Rodman & Renshaw Annual Healthcare Conference
BioSpace - program, including its ongoing clinical trial for hepatitis C infection and preclinical programs in influenza and other

Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
PR Newswire - Professor of Internal Medicine atUTMB, have been studying how Hepatitis C infection can damage or destroy theliver

OctoPlus Initiates Clinical Trials With Locteron(TM), a Controlled Release Formulation of Alfa Interferon
PR Newswire via Yahoo! - Alfa interferon is a protein used to treat infectious diseases, such as hepatitis B and C, and certain cancers. treatment of its primary indication, chronic hepatitis C infection.Locteron combines OctoPlus' proprietary PolyActive(TM

Peregrine Pharmaceuticals to Present at Rodman & Renshaw Annual Healthcare Conference
PR Newswire via Yahoo! - program, including its ongoing clinical trial for hepatitis C infection and preclinical programs in influenza and other

Early treatment of hepatitis C effective in HIV-positive patients
Aidsmap - Liver diseases including hepatitis C are an important cause of disease in HIV-positive patients. Treatment of hepatitis C infection during the early phase of infection can achieve similar response Although the treatment of chronic hepatitis C infection in HIV-positive patients